You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Not yet recruiting
  • Mycosis Fungoides of Skin (Diagnosis)
  • +5 more
  • Med-Jet Injector
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
2022-01-24
Jan 24, 2022
S
Completed
  • Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
    • Seoul, Gangnam-Gu, Korea, Republic of
      Samsung Medical Center
    2022-02-04
    Feb 4, 2022
    U
    Active, not recruiting
    • Anaplastic Large Cell Lymphoma, ALK-Positive
    • Monza, Italy/MB, Italy
      ASST-Monza
    2021-09-28
    Sep 28, 2021
    R
    Recruiting
    • Breast Implant-Associated Anaplastic Large Cell Lymphoma
    • +2 more
      • London, United Kingdom
      • +1 more
      2021-08-17
      Aug 17, 2021
      T
      Completed
      • Hodgkin Disease
      • Lymphoma, Large-Cell, Anaplastic
      • Brentuximab Vedotin
      • Beijing, Beijing, China
      • +6 more
      2021-02-03
      Feb 3, 2021
      C
      Recruiting
      • Anaplastic Large Cell Lymphoma
      • Vinorelbine
      • Shanghai, Shanghai, China
        Shanghai Children's Medical Center
      2021-07-28
      Jul 28, 2021
      F
      Withdrawn
      • Anaplastic Large Cell Lymphoma, ALK-Positive
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      2021-01-04
      Jan 4, 2021
      U
      Recruiting
      • Anaplastic Large Cell Lymphoma, ALK-Positive
      • Monza, Italy/MB, Italy
        Asst-Monza
      2021-09-28
      Sep 28, 2021
      N
      Active, not recruiting
      • Peripheral T-cell Lymphoma NOS
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-02-02
      Feb 2, 2022
      S
      Not yet recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • +4 more
      • anti-CD7 CAR-T cells
      • (no location specified)
      2022-03-18
      Mar 18, 2022
      N
      Active, not recruiting
      • Diffuse Large B-Cell Lymphoma (DLBCL)
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-03-31
      Mar 31, 2022
      P
      Not yet recruiting
      • Anaplastic Large Cell Lymphoma, ALK-Positive
      • +2 more
      • (no location specified)
      2021-06-07
      Jun 7, 2021
      A
      Terminated
      • ALK+ Anaplastic Large Cell Lymphoma
      • Wien, Austria
        Universitätsklinik f. Innere Medizin I, AKH Wien, Klinische Abte
      2022-02-15
      Feb 15, 2022
      H
      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +5 more
      • Guangzhou, Guangdong, China
        Department of Medical Oncology, Sun Yat-sen University Cancer Ce
      2021-03-10
      Mar 10, 2021
      H
      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +5 more
      • Guangzhou, Guangdong, China
        Department of hematology department, Nanfang hospital
      2021-03-12
      Mar 12, 2021
      Z
      Not yet recruiting
      • Hodgkin Lymphoma
      • +7 more
      • Anti CD30 CAR-T Cell Injection
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of medicine, Zhejiang Uni
      2022-01-12
      Jan 12, 2022
      A
      Recruiting
      • T Cell Non-Hodgkin Lymphoma
      • +3 more
      • AUTO4
      • Barcelona, Spain
      • +4 more
      2022-02-01
      Feb 1, 2022
      O
      Recruiting
      • Recurrent Anaplastic Large Cell Lymphoma
      • +8 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      2021-10-07
      Oct 7, 2021
      H
      Recruiting
      • Non-GCB/ABC Diffuse Large B-Cell Lymphoma
      • +5 more
      • Guangzhou, Guangdong, China
        Department of Medical Oncology, Sun Yat-sen University Cancer Ce
      2021-03-12
      Mar 12, 2021
      T
      Recruiting
      • Anaplastic Large Cell Lymphoma
      • +4 more
      • Duarte, California
      • +3 more
      2021-10-04
      Oct 4, 2021
      C
      Recruiting
      • Anaplastic Large Cell Lymphoma
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Duarte, California
      • +1 more
      2021-04-07
      Apr 7, 2021
      U
      Recruiting
      • Lymphoma
      • +12 more
      • ATLCAR.CD30.CCR4 cells
      • +3 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      2021-12-02
      Dec 2, 2021
      M
      Recruiting
      • Aggressive Non-Hodgkin Lymphoma
      • +14 more
      • Cholecalciferol
      • Laboratory Biomarker Analysis
      • Scottsdale, Arizona
      • +4 more
      2022-03-11
      Mar 11, 2022
      M
      Active, not recruiting
      • Follicular Lymphoma
      • +9 more
      • Boston, Massachusetts
      • +1 more
      2021-01-18
      Jan 18, 2021